Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

BAF53A antibody (AA 180-260)

The Rabbit Polyclonal anti-BAF53A antibody is suitable to detect BAF53A in samples from Human, Mouse and Rat. It has been validated for WB, IHC, ELISA and IF.
Catalog No. ABIN7225562
$379.10
Plus shipping costs $50.00
Shipping to: United States
Delivery in 12 to 16 Business Days

Quick Overview for BAF53A antibody (AA 180-260) (ABIN7225562)

Target

See all BAF53A Antibodies
BAF53A (Actin-Like 6A (BAF53A))

Reactivity

  • 86
  • 66
  • 47
  • 7
  • 7
  • 5
  • 5
  • 4
  • 4
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Human, Mouse, Rat

Host

  • 88
  • 9
Rabbit

Clonality

  • 65
  • 32
Polyclonal

Conjugate

  • 49
  • 6
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This BAF53A antibody is un-conjugated

Application

  • 74
  • 28
  • 26
  • 23
  • 22
  • 12
  • 6
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
  • Binding Specificity

    • 8
    • 6
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 180-260

    Purpose

    Rabbit Anti-BAF53 Polyclonal Antibody

    Specificity

    BAF53 Polyclonal Antibody detects endogenous levels of BAF53 protein.

    Purification

    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

    Immunogen

    Synthesized peptide derived from the Internal region of human BAF53 at AA range: 180-260

    Isotype

    IgG
  • Application Notes

    Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000,IHC 1:100-1:300,IF 1:200-1:1000,ELISA 1:10000,Not yet tested in other applications.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C

    Storage Comment

    Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

    Expiry Date

    12 months
  • Target

    BAF53A (Actin-Like 6A (BAF53A))

    Alternative Name

    BAF53

    Background

    ACTL6A, BAF53, BAF53A, INO80K, Actin-like protein 6A, 53 kDa BRG1-associated factor A, Actin-related protein Baf53a, ArpNbeta, BRG1-associated factor 53A, BAF53A, INO80 complex subunit KACTL6A (actin like 6A) encodes a family member of actin-related proteins (ARPs), which share significant amino acid sequence identity to conventional actins. Both actins and ARPs have an actin fold, which is an ATP-binding cleft, as a common feature. The ARPs are involved in diverse cellular processes, including vesicular transport, spindle orientation, nuclear migration and chromatin remodeling. ACTL6A encodes a 53 kDa subunit protein of the BAF (BRG1/brm-associated factor) complex in mammals, which is functionally related to SWI/SNF complex in S. cerevisiae and Drosophila, the latter is thought to facilitate transcriptional activation of specific genes by antagonizing chromatin-mediated transcriptional repression. Together with beta-actin, it is required for maximal ATPase activity of BRG1, and for the association of the BAF complex with chromatin/matrix. Three transcript variants that encode two different protein isoforms have been described.

    Molecular Weight

    47kD

    Gene ID

    86

    UniProt

    O96019

    Pathways

    Chromatin Binding, Photoperiodism
You are here:
Chat with us!